Immunogenicity and Safety of Three Dose Levels of OVX836 Candidate Vaccine Against Influenza in Healthy Volunteers.

NCT05060887 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

239

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza

Interventions

BIOLOGICAL: OVX836-003
BIOLOGICAL: Saline solution

Sponsor

Osivax

Collaborators

[object Object]